Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

计划入组 12 人 · 首次发布于 2015 年 6 月 23 日

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

首次发布于 2023 年 10 月 19 日

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

计划入组 12 人 · 首次发布于 2015 年 9 月 4 日

CDK12 Inhibitor

CDK12 inhibitors(Syros)

CDK12 inhibitors (cancer)

Cyclacel Completes Enrollment in Fadraciclib Trial for Tumors with CDKN2A/B Abnormalities

CATNON Trial Final Results Confirm Adjuvant Temozolomide Benefit in IDH-Mutant Anaplastic Glioma

Insilico Medicine Develops Novel AI-Designed CDK12/13 Inhibitors for Treatment-Resistant Cancers